Product Information
PAROXETINE MESYLATE 7.5 MG CAP is a generic product labeled by Padagis US LLC, priced at $2.6938 per EA under NDC 00574027930. Its NADAC has been published 449 times since Nov 22, 2017.
The High Outlier badge above means this manufacturer's average price in the paroxetine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7.5 mg/1
Manufacturer
Padagis US LLCNDC
00574027930
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE MESYLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204516On Market Since
10/3/2017
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE MESYLATE 7.5 MG CAP has been published 449 times since Nov 22, 2017, and over the history we have for it it has declined 39.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6938 per EA |
|---|---|
| All-time high | $4.5944 (May 11, 2022) |
| All-time low | $2.1647 (Aug 20, 2025) |
| 52-week high | $2.8717 |
| 52-week low | $2.1647 |
| Median price | $3.8199 |
| Average price | $3.6821 |
| Largest weekly change | +47.4% (Mar 20, 2024) |
| Weeks tracked | 449 |
| Tracking since | Nov 22, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAROXETINE MESYLATE 7.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE MESYLATE 7.5 MG CAP, manufactured by Padagis US LLC, is $2.6938 per EA (NDC 00574027930), effective Jun 24, 2026.
How has the price of PAROXETINE MESYLATE 7.5 MG CAP changed over time?
Over the history we have for it, the NADAC for PAROXETINE MESYLATE 7.5 MG CAP has declined 39.2%. It has been tracked across 449 weekly CMS publications since Nov 22, 2017.
What are the highest and lowest recorded NADAC prices for PAROXETINE MESYLATE 7.5 MG CAP?
Since Nov 22, 2017, the NADAC for PAROXETINE MESYLATE 7.5 MG CAP has ranged from a low of $2.1647 (Aug 20, 2025) to a high of $4.5944 (May 11, 2022), with a median of $3.8199 per EA.
Are there cheaper alternatives to PAROXETINE MESYLATE 7.5 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PAROXETINE MESYLATE 7.5 MG CAP, but none are currently priced below it.
Who manufactures PAROXETINE MESYLATE 7.5 MG CAP?
PAROXETINE MESYLATE 7.5 MG CAP (NDC 00574027930) is labeled by Padagis US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification